Micro-X Limited (ASX:MX1)
Australia
· Delayed Price · Currency is AUD 0.0660
-0.0010 (-1.49%)
At close: Mar 9, 2026
Micro-X Revenue
Micro-X had revenue of 11.25M AUD in the half year ending December 31, 2025, with 32.36% growth. This brings the company's revenue in the last twelve months to 16.90M, up 19.61% year-over-year. In the fiscal year ending June 30, 2025, Micro-X had annual revenue of 13.05M, down -14.25%.
Revenue (ttm)
16.90M
Revenue Growth
+19.61%
P/S Ratio
2.83
Revenue / Employee
n/a
Employees
n/a
Market Cap
47.77M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 13.05M | -2.17M | -14.25% |
| Jun 30, 2024 | 15.22M | 217.00K | 1.45% |
| Jun 30, 2023 | 15.01M | 6.04M | 67.28% |
| Jun 30, 2022 | 8.97M | 5.20M | 137.87% |
| Jun 30, 2021 | 3.77M | -480.00K | -11.29% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nova Eye Medical | 33.05M |
| HeraMED | 431.61K |
| CleanSpace Holdings | 20.66M |
| Compumedics | 58.49M |
| ImpediMed | 14.23M |
| Atomo Diagnostics | 3.92M |
| CurveBeam AI | 12.15M |
| Cleo Diagnostics | 2.56M |